Mankind Pharma front-runner to buy Bharat Serums, binding bids yet to be submitted
From a 52-week low of 1,661.05 in July 2023, the company's shares rose to a high of 2,490 in April 2024, though it has come off those highs now03-07-2024
03-07-2024
Mankind Pharma Ltd - 543904 - Closure of Trading Window
Closure of Trading Window under SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company''s ''Code of Conduct for Prohibition of Insider Trading''26-06-2024
Mankind Pharma Ltd - 543904 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Voting Result of Postal Ballot under Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 and Report of Scrutinizer Pursuant to section 108 & 110 of the Companies Act 2013 and rules made thereunder.18-06-2024
Mankind Pharma Ltd - 543904 - Shareholder Meeting / Postal Ballot-Outcome of Postal Ballot
Voting Result of Postal Ballot under Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Report of Scrutinizer Pursuant to Section 108 & 110 of the Companies Act, 2013 and Rules made thereunder.18-06-2024
Mankind Pharma - Disruptor With A Dose Of Care; Motilal Oswal Initiates Coverage With A Buy
Focus on chronic therapies to support growth13-06-2024
Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement in respect of Scheme of Arrangement for Amalgamation of Shree Jee Laboratory Private Limited, JPR Labs Private Limited and Jaspack Industries Private Limited ("Transferor Companies") with Mankind Pharma Limited ("Transferee Company"/"The Company") under Section 230-232 of the Companies Act, 2013 ("Scheme"/"Scheme of Amalgamation")07-06-2024
Mankind Pharma Ltd - 543904 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201503-06-2024
Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of participation in Investor Conference29-05-2024
Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Investor Conference Call for Q4FY24 - Transcript22-05-2024